Table 3. Summary of previous reports by other investigators of breath biomarkers of breast cancer.
Author #1 | Assay method | Outcome |
Hietanen [15] | GC | Increased pentane in breast cancer |
Mangler [14] | GC MS | Specific pattern of 5 VOCs in breast cancer: 3-methylhexane, decene, caryophyllene, naphthalene, and trichloroethylene |
Patterson [16] | GC MS | Clustering patterns in 383 VOCs classified breast cancer with 77% accuracy; 72% sensitivity, 64% specificity |
Peng [20] | Nanosensor array And GC MS | Differentiated between ‘healthy’ and ‘cancerous’ breath and different cancer types |
Stolarek [17] | Fluorimetry | Increased H2O2 level in exhaled breath condensate in breast cancer |
McCulloch [22] | Sniffing dogs | Detected breast cancer with sensitivity 88% and specificity 98% |
Shuster [18] | Nanosensor array | Statistically significant differences between benign and malignant breast conditions |
Xu [21] | Nanosensor array | Detected breast cancer with four VOCs: heptanal, acetophenone, isopropyl myristate and 2-propanol. |
Where assay techniques were employed that separated VOCs with gas chromatography (GC) and identified them with mass spectrometry (MS), a number of breath VOC biomarkers were consistent with products of oxidative stress e.g. pentane, hydrogen peroxide, and alkane derivatives including heptanal and propanol.